Assure (IONM) Stock Forecast, Price Target & Predictions
IONM Stock Forecast
Assure stock forecast is as follows: an average price target of $2.20K (represents a 1222122.22% upside from IONM’s last price of $0.18) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
IONM Price Target
The average price target for Assure (IONM) is $2.20K based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $2.20K to $2.20K. This represents a potential 1222122.22% upside from IONM's last price of $0.18.
IONM Analyst Ratings
According to 1 Wall Street analysts, Assure's rating consensus is 'Buy'. The analyst rating breakdown for IONM stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Assure Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 14, 2022 | Scott Henry | Roth Capital | $2.20K | $884.00 | 148.87% | 1222122.22% |
The latest Assure stock forecast, released on Jun 14, 2022 by Scott Henry from Roth Capital, set a price target of $2.20K, which represents a 148.87% increase from the stock price at the time of the forecast ($884.00), and a 1222122.22% increase from IONM last price ($0.18).
Assure Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.18 | $0.18 | $0.18 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Assure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Assure's last price of $0.18. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 14, 2022 | Roth Capital | - | Buy | Initialise |
Assure's last stock rating was published by Roth Capital on Jun 14, 2022. The company Initialise its IONM rating from "null" to "Buy".
Assure Financial Forecast
Assure Revenue Forecast
| Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $3.55M | $-1.57M | - | - | $4.70M | $9.66M | $8.55M | $6.22M | $4.76M | $5.96M | $3.96M | $-10.74M |
| Avg Forecast | $10.00M | $8.00M | $6.90M | $6.00M | $8.50M | $6.00M | $3.90M | $4.43M | $7.35M | $5.82M | $6.75M | $8.90M | $6.80M | $6.70M | $5.00M | $5.50M | $5.00M | $3.00M | $4.00M |
| High Forecast | $10.00M | $8.00M | $6.90M | $6.00M | $13.84M | $6.00M | $3.90M | $4.43M | $7.35M | $5.82M | $6.75M | $8.90M | $6.80M | $6.70M | $5.00M | $5.50M | $5.00M | $3.00M | $4.00M |
| Low Forecast | $10.00M | $8.00M | $6.90M | $6.00M | $3.16M | $6.00M | $3.90M | $4.43M | $7.35M | $5.82M | $6.75M | $8.90M | $6.80M | $6.70M | $5.00M | $5.50M | $5.00M | $3.00M | $4.00M |
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | 0.80% | -0.21% | - | - | 0.53% | 1.42% | 1.28% | 1.24% | 0.87% | 1.19% | 1.32% | -2.68% |
Assure's average Quarter revenue forecast for Jul 23 based on 0 analysts is $3.90M, with a low forecast of $3.90M, and a high forecast of $3.90M. IONM's average Quarter revenue forecast represents a 9.80% increase compared to the company's last Quarter revenue of $3.55M (Mar 23).
Assure EBITDA Forecast
| Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | $-3.08M | $-11.05M | - | - | $-3.80M | $335.00K | $806.00K | $-1.18M | $-1.35M | $-1.22M | $-575.00K | $-13.65M |
| Avg Forecast | $-5.77M | $-4.61M | $-3.98M | $-3.46M | $-4.90M | $-3.46M | $-2.25M | $-2.55M | $-4.24M | $-3.35M | $-3.89M | $-879.04K | $-2.08M | $-2.05M | $-1.53M | $-1.68M | $-1.53M | $-916.12K | $-1.22M |
| High Forecast | $-5.77M | $-4.61M | $-3.98M | $-3.46M | $-1.82M | $-3.46M | $-2.25M | $-2.55M | $-4.24M | $-3.35M | $-3.89M | $-703.23K | $-2.08M | $-2.05M | $-1.53M | $-1.68M | $-1.53M | $-916.12K | $-1.22M |
| Low Forecast | $-5.77M | $-4.61M | $-3.98M | $-3.46M | $-7.98M | $-3.46M | $-2.25M | $-2.55M | $-4.24M | $-3.35M | $-3.89M | $-1.05M | $-2.08M | $-2.05M | $-1.53M | $-1.68M | $-1.53M | $-916.12K | $-1.22M |
| Surprise % | - | - | - | - | - | - | - | 1.20% | 2.61% | - | - | 4.32% | -0.16% | -0.39% | 0.77% | 0.81% | 0.80% | 0.63% | 11.17% |
0 analysts predict IONM's average Quarter EBITDA for Mar 22 to be $-879.04K, with a high of $-703.23K and a low of $-1.05M. This is -362.40% lower than Assure's previous annual EBITDA (Dec 21) of $335.00K.
Assure Net Income Forecast
| Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | $-4.31M | $-21.49M | - | - | $-2.46M | $-309.00K | $91.00K | $-1.31M | $-1.23M | $-499.00K | $-977.00K | $-12.98M |
| Avg Forecast | $20.16M | $-7.56M | $-20.16M | $-28.98M | $5.04M | $-18.90M | $-70.56M | $-314.15M | $-151.20M | $-571.19M | $-11.90M | $-1.01M | $-48.35M | $-6.04M | $6.11M | $6.04M | $12.09M | $-12.09M | - |
| High Forecast | $20.16M | $-7.56M | $-20.16M | $-28.98M | $5.04M | $-18.90M | $-70.56M | $-314.15M | $-151.20M | $-571.19M | $-11.90M | $-811.47K | $-48.35M | $-6.04M | $6.11M | $6.04M | $12.09M | $-12.09M | - |
| Low Forecast | $20.16M | $-7.56M | $-20.16M | $-28.98M | $5.04M | $-18.90M | $-70.56M | $-314.15M | $-151.20M | $-571.19M | $-11.90M | $-1.22M | $-48.35M | $-6.04M | $6.11M | $6.04M | $12.09M | $-12.09M | - |
| Surprise % | - | - | - | - | - | - | - | 0.01% | 0.14% | - | - | 2.42% | 0.01% | -0.02% | -0.21% | -0.20% | -0.04% | 0.08% | - |
Assure's average Quarter net income forecast for Dec 21 is $-48.35M, with a range of $-48.35M to $-48.35M. IONM's average Quarter net income forecast represents a -53228.41% decrease compared to the company's last Quarter net income of $91.00K (Sep 21).
Assure SG&A Forecast
| Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | $3.34M | $4.14M | - | - | $4.49M | $4.86M | $3.43M | $4.13M | $3.47M | $4.15M | $2.31M | $1.87M |
| Avg Forecast | $117.32M | $93.86M | $80.95M | $70.39M | $99.72M | $70.39M | $45.75M | $51.96M | $86.20M | $68.25M | $79.19M | $1.85M | $8.21M | $8.09M | $6.04M | $6.64M | $6.04M | $3.62M | $4.83M |
| High Forecast | $117.32M | $93.86M | $80.95M | $70.39M | $162.37M | $70.39M | $45.75M | $51.96M | $86.20M | $68.25M | $79.19M | $2.22M | $8.21M | $8.09M | $6.04M | $6.64M | $6.04M | $3.62M | $4.83M |
| Low Forecast | $117.32M | $93.86M | $80.95M | $70.39M | $37.08M | $70.39M | $45.75M | $51.96M | $86.20M | $68.25M | $79.19M | $1.48M | $8.21M | $8.09M | $6.04M | $6.64M | $6.04M | $3.62M | $4.83M |
| Surprise % | - | - | - | - | - | - | - | 0.06% | 0.05% | - | - | 2.42% | 0.59% | 0.42% | 0.68% | 0.52% | 0.69% | 0.64% | 0.39% |
Assure's average Quarter SG&A projection for Jul 23 is $45.75M, based on 0 Wall Street analysts, with a range of $45.75M to $45.75M. The forecast indicates a 1270.30% rise compared to IONM last annual SG&A of $3.34M (Mar 23).
Assure EPS Forecast
| Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | $-4.09 | $-28.60 | - | - | $-3.81 | $-0.50 | $0.20 | $-2.20 | $-2.20 | $-1.00 | $-2.80 | $-38.00 |
| Avg Forecast | $2.88 | $-1.08 | $-2.88 | $-4.14 | $0.72 | $-2.70 | $-10.08 | $-44.88 | $-21.60 | $-81.60 | $-1.70 | $-0.40 | $-8.00 | $-1.00 | $1.01 | $1.00 | $2.00 | $-2.00 | - |
| High Forecast | $2.88 | $-1.08 | $-2.88 | $-4.14 | $0.72 | $-2.70 | $-10.08 | $-44.88 | $-21.60 | $-81.60 | $-1.70 | $-0.40 | $-8.00 | $-1.00 | $1.01 | $1.00 | $2.00 | $-2.00 | - |
| Low Forecast | $2.88 | $-1.08 | $-2.88 | $-4.14 | $0.72 | $-2.70 | $-10.08 | $-44.88 | $-21.60 | $-81.60 | $-1.70 | $-0.40 | $-8.00 | $-1.00 | $1.01 | $1.00 | $2.00 | $-2.00 | - |
| Surprise % | - | - | - | - | - | - | - | 0.09% | 1.32% | - | - | 9.53% | 0.06% | -0.20% | -2.18% | -2.20% | -0.50% | 1.40% | - |
According to 0 Wall Street analysts, Assure's projected average Quarter EPS for Dec 21 is $-8.00, with a low estimate of $-8.00 and a high estimate of $-8.00. This represents a -4100.00% decrease compared to IONM previous annual EPS of $0.20 (Sep 21).
Assure Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| IONM | Assure | $0.18 | $2.20K | 1222122.22% | Buy |
| TOI | Oncology Institute | $0.33 | $8.00 | 2324.24% | Buy |
| CANO | Cano Health | $2.30 | $6.42 | 179.13% | Buy |
| AIRS | AirSculpt | $4.03 | $6.67 | 65.51% | Hold |
| AGL | agilon health | $3.53 | $5.50 | 55.81% | Buy |
| AMED | Amedisys | $96.91 | $143.38 | 47.95% | Hold |
| ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
| PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
| AVAH | Aveanna Healthcare | $5.39 | $4.10 | -23.93% | Buy |
| HCA | HCA Healthcare | $394.68 | $291.95 | -26.03% | Buy |
| SNDA | Sonida Senior Living | $26.58 | $13.00 | -51.09% | Sell |
IONM Forecast FAQ
Is Assure a good buy?
Yes, according to 1 Wall Street analysts, Assure (IONM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of IONM's total ratings.
What is IONM's price target?
Assure (IONM) average price target is $2.2K with a range of $2.2K to $2.2K, implying a 1222122.22% from its last price of $0.18. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Assure stock go up soon?
According to Wall Street analysts' prediction for IONM stock, the company can go up by 1222122.22% (from the last price of $0.18 to the average price target of $2.2K), up by 1222122.22% based on the highest stock price target, and up by 1222122.22% based on the lowest stock price target.
Can Assure stock reach $0?
IONM's average twelve months analyst stock price target of $2.2K supports the claim that Assure can reach $0 in the near future.
What are Assure's analysts' financial forecasts?
Assure's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $22.83M (high $28.17M, low $17.49M), average EBITDA is $-13.166M (high $-10.086M, low $-16.245M), average net income is $-399M (high $-399M, low $-399M), average SG&A $267.83M (high $330.48M, low $205.19M), and average EPS is $-56.94 (high $-56.94, low $-56.94). IONM's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $30.9M (high $30.9M, low $30.9M), average EBITDA is $-17.82M (high $-17.82M, low $-17.82M), average net income is $-36.539M (high $-36.539M, low $-36.539M), average SG&A $362.52M (high $362.52M, low $362.52M), and average EPS is $-5.22 (high $-5.22, low $-5.22).
Did the IONM's actual financial results beat the analysts' financial forecasts?
Based on Assure's last annual report (Dec 2022), the company's revenue was $10.98M, which missed the average analysts forecast of $28.81M by -61.91%. Apple's EBITDA was $-22.236M, beating the average prediction of $-12.364M by 79.84%. The company's net income was $-30.112M, missing the average estimation of $-735M by -95.90%. Apple's SG&A was $16.01M, missing the average forecast of $235.49M by -93.20%. Lastly, the company's EPS was $-40.06, missing the average prediction of $-105 by -61.96%. In terms of the last quarterly report (Mar 2023), Assure's revenue was $3.55M, missing the average analysts' forecast of $4.43M by -19.81%. The company's EBITDA was $-3.077M, beating the average prediction of $-2.554M by 20.46%. Assure's net income was $-4.314M, missing the average estimation of $-314M by -98.63%. The company's SG&A was $3.34M, missing the average forecast of $51.96M by -93.57%. Lastly, the company's EPS was $-4.09, missing the average prediction of $-44.88 by -90.89%